Back
Celldex Therapeutics Stock Predictions
Sponsored
CLDX
Sponsored
Elon's Secret "A.I. 2.0" Project
Click here now to discover how to claim a stake in Elon's "A.I. 2.0" project
Sell
47
CLDX
Celldex Therapeutics
Last Price:
36.96
Seasonality Move:
14.42%
7 Day Trial
ALL ACCESS PASS
$
7
Unlock the Secret to Earning Monthly Income!
Limited spots act swiftlyCelldex Therapeutics Stock Forecast
- Over the next 52 weeks, Celldex Therapeutics has on average historically risen by 36.1% based on the past 37 years of stock performance.
- Celldex Therapeutics has risen higher in 14 of those 37 years over the subsequent 52-week period, corresponding to a historical accuracy of 37.84%
-
Is Celldex Therapeutics Stock Undervalued?
The current Celldex Therapeutics [CLDX] share price is $37.02. The Score for CLDX is 47, which is 6% below its historic median score of 50, and infers higher risk than normal. - CLDX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Celldex Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Celldex Therapeutics has on average historically risen by 36.1% based on the past 37 years of stock performance.
Celldex Therapeutics Stock Rating
Sell
47
Celldex Therapeutics (CLDX)
is a Sell
Is Celldex Therapeutics overpriced?
- Celldex Therapeutics has risen higher in 14 of those 37 years over the subsequent 52-week period, corresponding to a historical accuracy of 37.84%
Celldex Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
celldex.com
52-Week Data
52-Week High:
53.18
52-Week Low:
22.11
Prediction Charts
Market Cap:
2.07B
Price in USD:
37.02
Volume:
394.62K
Beta:
1.81
Technical Analysis
SMA50:
41.95
SMA100:
39.56
SMA200:
34.32
52-Wk Change:
6.59%
Stock Predictions
-
Is Celldex Therapeutics stock public?
Yes, Celldex Therapeutics is a publicly traded company. -
What is the Celldex Therapeutics stock quote today?
The Celldex Therapeutics stock price is 37.02 USD today. -
How to buy Celldex Therapeutics stock online?
You can buy Celldex Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Apr-5 | 39.01 | 39.61 | 40.61 | 38.55 |
Apr-8 | 39.89 | 39.72 | 39.89 | 38.89 |
Apr-9 | 39.75 | 40.62 | 40.66 | 39.40 |
Apr-10 | 39.33 | 39.17 | 39.44 | 38.10 |
Apr-11 | 39.63 | 40.87 | 41.67 | 39.03 |
Apr-12 | 40.53 | 39.25 | 40.86 | 38.56 |
Apr-15 | 39.44 | 39.09 | 40.12 | 38.69 |
Apr-16 | 39.03 | 38.59 | 39.27 | 38.14 |
Apr-17 | 39.01 | 39.63 | 40.45 | 38.67 |
Apr-18 | 39.41 | 38.48 | 39.94 | 38.29 |
Apr-19 | 38.24 | 37.98 | 38.50 | 36.78 |
Apr-22 | 38.50 | 38.85 | 39.41 | 37.99 |
Apr-23 | 38.91 | 37.74 | 39.67 | 37.62 |
Apr-24 | 37.87 | 37.02 | 38.00 | 36.96 |
Celldex Therapeutics Earnings
Celldex Therapeutics Earnings Report: Per Share Celldex Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Celldex Therapeutics Forecast Revenue Growth
Celldex Therapeutics Stock Analysis: Historical quarterly revenues per share for Celldex Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.16 per share, and a decrease next year of $0.05 per share.
* Celldex Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.